Search results
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Zacks· 4 days agoThe ability to identify stocks that are likely to top quarterly earnings expectations can be profitable, but it's no simple task. The Zacks Earnings ESP is more formally known as the Expected ...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 5 days agoWhile AstraZeneca’s top line was driven by increased demand for its key oncology and rare disease...
Trials to watch: Four ALS drugs to keep an eye on
Clinical Trials Arena via Yahoo Finance· 5 days agoGlobalData is the parent company of the Clinical Trials Arena. HEALEY Platform trial investigates Calico and AbbVie drug The HEALEY ALS Platform Trial...
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Zacks via Yahoo Finance· 4 days agoANI Pharmaceuticals' Earnings ESP sits at 9.74%, which, as explained above, is calculated by taking...
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 4 days agoThe drug’s Danish manufacturer, Novo Nordisk, declined to comment. FTC’s latest announcement follows...
3 Top Dividend Stocks to Maximize Your Retirement Income
Zacks via Yahoo Finance· 5 days agoThe traditional retirement planning approaches no longer cover all expenses in nest egg years. So...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KFDX Wichita Falls· 4 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
Coming to a CVS Near You: A Store Brand Monoclonal Antibody
The Wall Street Journal· 6 days agoAbbVie’s decision to offer steep rebates—basically payments to the PBMs, much of which is passed on...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 3 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
FOX 8 Cleveland· 4 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
